• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Oncology

Latest News

The report offers strong evidence affirming previous reports suggesting that people with obesity may be at a heightened risk of DLBCL. | Image Credit: zhuan - stock.adobe.com
Genetic Obesity Linked With DLBCL Risk

October 28th 2025

New reporting suggests obesity and diffuse large B-cell lymphoma (DLBCL) have shared genetic risk factors.

The authors say more research is warranted to identify novel therapies that improve response and disease control in patients with ES-SCLC in the third line. | Image credit: Crystal light - stock.adobe.com
Real-World Outcomes From Third-Line SCLC Treatment Show Need for More Options

October 24th 2025

Combining CAR T cells with first-line therapies like immune checkpoint inhibitors may ultimately prove to be the best method of deployment for CAR T in SCLC. | Image credit: Alpha Tauri 3D - stock.adobe.com
CAR T-Cell Therapy Holds Potential in SCLC, but Significant Barriers Remain

October 8th 2025

As survivorship grows integrating whole-person care, from functional restoration to emotional resilience, will be key to helping patients with soft tissue sarcoma reclaim their lives. | Image credit: VitaliiVodolazskyi - stock.adobe.com
Addressing Psychosocial Barriers Key During Soft Tissue Sarcoma Surgery Recovery

October 8th 2025

The authors said blood-based biomarkers for ICI response should be a research priority in soft tissue sarcoma moving forward. | Image credit: Dzmitry - stock.adobe.com
Blood-Based Biomarkers Could Reshape Soft Tissue Sarcoma Therapy

September 30th 2025

Latest CME Events & Activities

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology

View More

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

View More

<1
...
186187188189190
© 2025 MJH Life Sciences
AJMC®
All rights reserved.